Moderna's updated COVID-19 vaccine is coming to Alberta
Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the Court of Appeal. Pfizer and its German partner BioNTech sued Moderna in London in September 2022,
Why Australia could miss out on Moderna's new COVID-19 vaccine
While Australia's therapeutic goods regulator is evaluating two new vaccines targeting the JN.1 strain of COVID-19, the government seemingly only intends to make one available to the public.
Moderna's updated COVID-19 vaccine is coming to Alberta, but Novavax shots are not
With the approval of Moderna's updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans will opt to roll up their sleeves to get one.
On the hunt for Novavax: Why people are seeking out the 'traditional' COVID vaccine
Although Pfizer's and Moderna’s COVID-19 vaccines have been stealing the spotlight for years, some people are actively seeking out the lesser-known Novavax for their updated booster this fall. Multiple people have been claiming on social media that Novavax comes with fewer side effects or none at all — “not even a sore arm,
Health Canada approves Pfizer's updated COVID-19 vaccine, manufacturer says
Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.
FiercePharma3d
Moderna blamed after kids offered $2,000 to participate in COVID-19 vaccine trial
The PCMPA has slammed Moderna over an unapproved WhatsApp message that offered children 1,500 pounds sterling ($2,000) to ...
COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...
Axios Vitals on MSN15d
Moderna is dialing back its vaccine ambitions
Moderna is dialing back its plans for new vaccines, shelving several key projects as it grapples with a sharp slowdown in ...
Moderna’s ‘Off-the-Shelf’ Cancer Vaccine Shows Promise in Early Human Trial Data
The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...
As GSK discontinues HSV vaccine, opportunities remain for Moderna and BioNTech
GSK's decision not to advance the vaccine into Phase III trials ends its ambition to bring the first HSV vaccine to market.
Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans
Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...
CNET on MSN6d
What to Know About Novavax, the 'Other' COVID Vaccine
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
Moderna: Still Bullish View
Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...
Moderna Shares Fall As Vaccine Maker Cuts R&D Spending Plans
Moderna shares were hit a little over a month ago when the company cut its 2024 net sales guidance to a range of $3 billion to $3.5 billion from a previous $4 billion.
Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRNA
NDAQ:MRNA) Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRNA ...